In short
Well-designed in vivo research starts with a clear biological question, justified model selection, appropriate controls, predefined endpoints, ethical approval and transparent reporting. Manna Biotech supports suitable non-clinical research workflows subject to scientific feasibility, facility scope and required approvals.
What a rigorous in vivo study requires
- A clearly defined hypothesis and primary endpoint
- A justified model matched to the research question
- Appropriate negative, vehicle and positive controls where scientifically relevant
- Predefined inclusion, exclusion and stopping criteria
- Randomisation, blinding and reproducible documentation where feasible
- Statistical planning aligned with the design rather than added after data collection
From in vitro evidence to in vivo validation
In vivo work is strongest when it is supported by a logical evidence chain. Preliminary in vitro, biochemical, molecular or computational findings can help justify the model, dose range and endpoints before animal work begins.
The goal is not to add an animal experiment simply for completeness, but to answer a question that cannot be resolved adequately with a lower-complexity model.
Ethics, welfare and approvals
Animal work must be undertaken only with the appropriate institutional permissions, ethical oversight, trained personnel and facility controls required for the specific study. Manna Biotech accepts only projects that fit available capabilities and applicable approval requirements.
Common endpoint categories
- Clinical or behavioural observations appropriate to the model
- Body-weight, intake or other longitudinal measures when relevant
- Biochemical and histopathology endpoints where included in the approved protocol
- Molecular endpoints such as gene-expression analysis when scientifically justified
- Integrated interpretation across in vivo, in vitro and computational datasets
Frequently asked questions
Does Manna Biotech support in vivo research in Hyderabad?+
Manna Biotech supports suitable non-clinical in vivo research projects subject to scientific feasibility, facility scope and the approvals required for the specific study.
Can an in vivo study be combined with molecular analysis?+
Yes, where scientifically justified, an in vivo design can be integrated with biochemical, histological or molecular endpoints such as gene-expression analysis.
Do all projects automatically qualify for animal studies?+
No. Model choice, ethical justification, facility suitability and approvals must be assessed before an in vivo component is accepted.
Can in vitro results be used to plan an in vivo study?+
Yes. In vitro and related preliminary evidence can help justify model selection, dose planning and endpoint selection when interpreted appropriately.